Investment in the Manufacture of Pharmaceutical Products and Medical Supplies in Tanzania

Jan. 20, 2026
PDF 77.pdf Download attachment →

Dear Esteemed Chamber Subscribers,

May the peace, mercy, and blessings of Allah be upon you.

Asharqia Chamber extends its warmest greetings to you and would like to inform you that it has received the letter of the Federation of Saudi Chambers No. (45543886/19), dated (29/7/1447 AH), which refers to the Ministry of Foreign Affairs telegram No. (200305- 47 – 001), dated (23/7/1447 AH), which includes the Ministry’s receipt of a note from the Embassy of the United Republic of Tanzania in Riyadh regarding the invitation of the Tanzanian Ministry of Health to those interested in investing in the manufacture of pharmaceutical products and medical supplies in the Republic of Tanzania. This invitation aims to attract qualified investors, consortia, and strategic partners to contribute to establishing or expanding pharmaceutical manufacturing facilities, including essential medicines, vaccines, active pharmaceutical ingredients, and medical supplies, within the government-approved fast-track approval system and the pharmaceutical industries investment acceleration program, in a manner that enhances technology transfer, ensures a reliable supply of health products, and is in line with the national manufacturing agenda and the transformation of the health sector in the Republic of Tanzania. The Embassy hopes that the competent authorities, bodies, and stakeholders in the Kingdom will take part and urge those wishing to invest in the health field to express interest.

For more information and coordination, your specialists may contact the Secretary of the Saudi-Tanzanian Business Council, Mr. Waleed bin Ladnah, on mobile number: 0537405651 or by email. Wladnah@fsc.org.sa:

Please accept our sincere regards and appreciation.


← Back to memos 20/01/2026